{"schema_version":"secwatch.filing_event.v1","accession":"0000860748-25-000225","form_type":"8-K","ticker":"KMPR","cik":"0000860748","company_name":"KEMPER Corp","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.386854+00:00","generated_at":"2026-05-16T22:49:13.759977+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kemper grants $2.225M retention RSUs to CFO, CIO, and Auto president","bullets":["CFO Camden receives $775k retention RSU; vests 50% at year one and 50% at year two.","CIO Boschelli receives $675k retention RSU; same two-year vesting schedule.","Auto president Hunton receives $775k retention RSU; same vesting terms.","Awards follow recent leadership changes; approved by compensation committee after consultant review.","Grant date expected to be first trading day of December 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000860748-25-000225","json":"https://secwatch.observer/filing/0000860748-25-000225.json","markdown":"https://secwatch.observer/filing/0000860748-25-000225.md","text":"https://secwatch.observer/filing/0000860748-25-000225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860748/000086074825000225/0000860748-25-000225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860748/000086074825000225/kmpr-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:49:13.759977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001171843-26-003793","ticker":"EDSA","company_name":"Edesa Biotech, Inc.","filed_at":"2026-05-29T20:15:18+00:00","headline":"Edesa Biotech shareholders approve equity plan amendment adding 750K shares","event_type":"other","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 5.02, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003793","json":"https://secwatch.observer/filing/0001171843-26-003793.json","markdown":"https://secwatch.observer/filing/0001171843-26-003793.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062119","ticker":"ONDS","company_name":"Ondas Inc.","filed_at":"2026-05-28T20:09:45+00:00","headline":"Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares","event_type":"other","sec_items":["5.02","5.07","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 5.02, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062119","json":"https://secwatch.observer/filing/0001213900-26-062119.json","markdown":"https://secwatch.observer/filing/0001213900-26-062119.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1646188/000121390026062119/0001213900-26-062119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1646188/000121390026062119/ea0292551-8k_ondas.htm"},"side_by_side_evidence":null},{"accession":"0001178253-26-000017","ticker":"SCYX","company_name":"SCYNEXIS INC","filed_at":"2026-05-29T20:01:37+00:00","headline":"SCYNEXIS effects 1:8 reverse stock split; authorized shares cut to 18.75M","event_type":"other","sec_items":["5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001178253-26-000017","json":"https://secwatch.observer/filing/0001178253-26-000017.json","markdown":"https://secwatch.observer/filing/0001178253-26-000017.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/0001178253-26-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/scyx-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062184","ticker":"RLMD","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2026-05-28T20:59:47+00:00","headline":"Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment","event_type":"other","sec_items":["5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same SEC item: 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062184","json":"https://secwatch.observer/filing/0001213900-26-062184.json","markdown":"https://secwatch.observer/filing/0001213900-26-062184.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/ea0292521-8k_relmada.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-245337","ticker":"AVBC","company_name":"Avidia Bancorp, Inc.","filed_at":"2026-05-28T20:32:58+00:00","headline":"Avidia Bancorp posts investor presentation for June 2 conference","event_type":"other","sec_items":["7.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-245337","json":"https://secwatch.observer/filing/0001193125-26-245337.json","markdown":"https://secwatch.observer/filing/0001193125-26-245337.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2058758/000119312526245337/0001193125-26-245337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2058758/000119312526245337/avbc-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001171843-26-003730","ticker":"HAFC","company_name":"HANMI FINANCIAL CORP","filed_at":"2026-05-27T22:15:32+00:00","headline":"Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP","event_type":"other","sec_items":["5.02","5.07","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same SEC item: 5.02, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003730","json":"https://secwatch.observer/filing/0001171843-26-003730.json","markdown":"https://secwatch.observer/filing/0001171843-26-003730.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109242/000117184326003730/0001171843-26-003730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109242/000117184326003730/f8k_052726.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063610","ticker":"PAL","company_name":"Proficient Auto Logistics, Inc","filed_at":"2026-06-01T21:29:32+00:00","headline":"Proficient Auto Logistics to attend William Blair conference; sets Q2 2026 earnings call for Aug 10","event_type":"other","sec_items":["7.01","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same SEC item: 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063610","json":"https://secwatch.observer/filing/0001213900-26-063610.json","markdown":"https://secwatch.observer/filing/0001213900-26-063610.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1998768/000121390026063610/0001213900-26-063610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1998768/000121390026063610/ea0293071-8k_proficient.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251784","ticker":"REVB","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2026-06-01T21:26:39+00:00","headline":"Revelation Biosciences releases updated corporate presentation without disclosed details","event_type":"other","sec_items":["8.01","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same SEC item: 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251784","json":"https://secwatch.observer/filing/0001193125-26-251784.json","markdown":"https://secwatch.observer/filing/0001193125-26-251784.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526251784/0001193125-26-251784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526251784/revb-20260601.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}